ACI Formulations Limited (DSE: ACIFORMULA)

ACI Formulations Revenue

ACI Formulations had revenue of 1.23B BDT in the quarter ending March 31, 2024, a decrease of -5.71%. This brings the company's revenue in the last twelve months to 4.97B, up 2.92% year-over-year. In the fiscal year ending June 30, 2023, ACI Formulations had annual revenue of 4.96B with 16.77% growth.

• Revenue (ttm): 4.97B
• Revenue Growth: +2.92%
• P/S Ratio: 1.14
• Revenue / Employee: 5.05M
• Employees: 985
• Market Cap: 5.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	4.96B	712.39M	16.77%
Jun 30, 2022	4.25B	382.88M	9.91%
Jun 30, 2021	3.86B	440.49M	12.86%
Jun 30, 2020	3.42B	-628.33M	-15.51%
Jun 30, 2019	4.05B	-100.90M	-2.43%